Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties
- 26 April 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (11) , 2110-2116
- https://doi.org/10.1021/jm020329q
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The endocannabinoid nervous system: Unique opportunities for therapeutic interventionPharmacology & Therapeutics, 2001
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996
- Practical Synthesis of 1H-Indazole-3-carboxylic Acid and Its DerivativesHETEROCYCLES, 1996
- Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid MimeticsJournal of Medicinal Chemistry, 1995
- Cluster analysis of molecular conformationsJournal of Computational Chemistry, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Conformationally restrained analogs of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptorJournal of Medicinal Chemistry, 1992
- Synthesis of 2-exo- and 2-endo-mecamylamine analogs. Structure-activity relationships for nicotinic antagonism in the central nervous systemJournal of Medicinal Chemistry, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanicsJournal of Computational Chemistry, 1990